Cng Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 14-12-2024
- Paid Up Capital ₹ 1.95 M
as on 14-12-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 38.27 Cr
as on 14-12-2024
- Revenue 18.18%
(FY 2022)
- Profit 48.93%
(FY 2022)
- Ebitda 27.61%
(FY 2022)
- Net Worth 16.21%
(FY 2022)
- Total Assets 3.20%
(FY 2022)
About Cng Superspeciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.95 M.
The company currently has active open charges totaling ₹38.27 Cr.
Arvind Kalla and Dhruva Sharma serve as directors at the Company.
- CIN/LLPIN
U85110RJ2013PTC041892
- Company No.
041892
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2013
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jodhpur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cng Superspeciality Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Kalla  | Director | 21-Mar-2013 | Current |
| Dhruva Sharma | Director | 21-Mar-2013 | Current |
Financial Performance of Cng Superspeciality Hospital.
Cng Superspeciality Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.18% increase. The company also saw a substantial improvement in profitability, with a 48.93% increase in profit. The company's net worth Soared by an impressive increase of 16.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cng Superspeciality Hospital?
In 2022, Cng Superspeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mukundam Hospital And Kidney Centre Private LimitedActive 14 years 9 monthsArvind Kalla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Mar 2024 | ₹33.00 Cr | Open |
State Bank Of India Creation Date: 19 Aug 2023 | ₹3.28 M | Open |
Hdfc Bank Limited Creation Date: 05 Feb 2021 | ₹1.05 M | Open |
How Many Employees Work at Cng Superspeciality Hospital?
Unlock and access historical data on people associated with Cng Superspeciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cng Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cng Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
